Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert D'Haens

Showing results (71-80 of 269) with videos related to

Pageof 27
Sort By:
Gastroenterology|April 29, 2008
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trialGert Van Assche, Charlotte Magdelaine-Beuzelin, Geert D'Haens, et al.
Clinical Drug Investigation|April 2, 2023
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical TrialGeert D'Haens, Walter Reinisch, Stefan Schreiber, et al.
Inflammatory Bowel Diseases|July 29, 2009
Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case seriesMarc Ferrante, Geert D'Haens, Olivier Dewit, et al.
Journal of Crohn'S & Colitis|March 13, 2012
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel diseaseAlessandro Armuzzi, Gert Van Assche, Walter Reinisch, et al.
Inflammatory Bowel Diseases|February 15, 2023
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 DataSilvio Danese, Jacinda Tran, Geert D'Haens, et al.
Clinical and Translational Gastroenterology|August 18, 2023
Mirikizumab-Induced Transcriptome Changes in Ulcerative Colitis Patient Biopsies at Week 12 Are Maintained Through Week 52Travis Johnson, Boyd Steere, Pengyue Zhang, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 29, 2022
Long-term Temporal Stability of Peripheral Blood DNA Methylation Profiles in Patients With Inflammatory Bowel DiseaseVincent Joustra, Andrew Y F Li Yim, Ishtu Hageman, et al.
The American Journal of Gastroenterology|November 12, 2020
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIXPauline Rivière, Geert D'Haens, Laurent Peyrin-Biroulet, et al.
The Cochrane Database of Systematic Reviews|July 22, 2017
Histologic scoring indices for evaluation of disease activity in Crohn's diseaseGregor Novak, Claire E Parker, Rish K Pai, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 16, 2024
Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trialStefan Schreiber, Geert D'Haens, Fraser Cummings, et al.
Pageof 27

Showing results (71-80 of 269) with videos related to

Sort By:
Pageof 27
Gastroenterology|April 29, 2008
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trialGert Van Assche, Charlotte Magdelaine-Beuzelin, Geert D'Haens, et al.
Clinical Drug Investigation|April 2, 2023
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical TrialGeert D'Haens, Walter Reinisch, Stefan Schreiber, et al.
Inflammatory Bowel Diseases|July 29, 2009
Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case seriesMarc Ferrante, Geert D'Haens, Olivier Dewit, et al.
Journal of Crohn'S & Colitis|March 13, 2012
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel diseaseAlessandro Armuzzi, Gert Van Assche, Walter Reinisch, et al.
Inflammatory Bowel Diseases|February 15, 2023
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 DataSilvio Danese, Jacinda Tran, Geert D'Haens, et al.
Clinical and Translational Gastroenterology|August 18, 2023
Mirikizumab-Induced Transcriptome Changes in Ulcerative Colitis Patient Biopsies at Week 12 Are Maintained Through Week 52Travis Johnson, Boyd Steere, Pengyue Zhang, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 29, 2022
Long-term Temporal Stability of Peripheral Blood DNA Methylation Profiles in Patients With Inflammatory Bowel DiseaseVincent Joustra, Andrew Y F Li Yim, Ishtu Hageman, et al.
The American Journal of Gastroenterology|November 12, 2020
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIXPauline Rivière, Geert D'Haens, Laurent Peyrin-Biroulet, et al.
The Cochrane Database of Systematic Reviews|July 22, 2017
Histologic scoring indices for evaluation of disease activity in Crohn's diseaseGregor Novak, Claire E Parker, Rish K Pai, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 16, 2024
Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trialStefan Schreiber, Geert D'Haens, Fraser Cummings, et al.
Pageof 27